DE2441621A1 - Arzneimittel zur behandlung von augenerkrankungen - Google Patents

Arzneimittel zur behandlung von augenerkrankungen

Info

Publication number
DE2441621A1
DE2441621A1 DE2441621A DE2441621A DE2441621A1 DE 2441621 A1 DE2441621 A1 DE 2441621A1 DE 2441621 A DE2441621 A DE 2441621A DE 2441621 A DE2441621 A DE 2441621A DE 2441621 A1 DE2441621 A1 DE 2441621A1
Authority
DE
Germany
Prior art keywords
gel
cysteine
free
oxygen
inert gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2441621A
Other languages
German (de)
English (en)
Other versions
DE2441621C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Bernd Dr Hempel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robugen GmbH
Original Assignee
Robugen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robugen GmbH filed Critical Robugen GmbH
Priority to DE2441621A priority Critical patent/DE2441621A1/de
Publication of DE2441621A1 publication Critical patent/DE2441621A1/de
Application granted granted Critical
Publication of DE2441621C2 publication Critical patent/DE2441621C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2441621A 1974-08-30 1974-08-30 Arzneimittel zur behandlung von augenerkrankungen Granted DE2441621A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2441621A DE2441621A1 (de) 1974-08-30 1974-08-30 Arzneimittel zur behandlung von augenerkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2441621A DE2441621A1 (de) 1974-08-30 1974-08-30 Arzneimittel zur behandlung von augenerkrankungen

Publications (2)

Publication Number Publication Date
DE2441621A1 true DE2441621A1 (de) 1976-03-11
DE2441621C2 DE2441621C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-01-21

Family

ID=5924498

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2441621A Granted DE2441621A1 (de) 1974-08-30 1974-08-30 Arzneimittel zur behandlung von augenerkrankungen

Country Status (1)

Country Link
DE (1) DE2441621A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004680A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic gel
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
EP0213091A1 (en) * 1985-08-05 1987-03-04 Michele Testa Use of compounds for the manufacture of a medicament for the treatment of cataract
FR2608428A1 (fr) * 1985-11-27 1988-06-24 Senju Pharma Co Composition therapeutique a base de cysteine, pour les complications diabetiques
CN115094426A (zh) * 2022-08-01 2022-09-23 哈尔滨工程大学 一种基于协同机制构筑的复合缓蚀剂的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2203623A1 (en) * 1972-10-23 1974-05-17 Bfb Compsns contg cysteine and dithio threitol - eye-drops for treatment of corneal disorders in which collagenase occurs in the cornea

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2203623A1 (en) * 1972-10-23 1974-05-17 Bfb Compsns contg cysteine and dithio threitol - eye-drops for treatment of corneal disorders in which collagenase occurs in the cornea

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
F.GSIRNER, Einführung in die Verfahrenstechnik der Arzneiformung, S. 312-317 (1973) *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004680A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic gel
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
EP0213091A1 (en) * 1985-08-05 1987-03-04 Michele Testa Use of compounds for the manufacture of a medicament for the treatment of cataract
US4797422A (en) * 1985-08-05 1989-01-10 Michele Testa Pharmaceutical compounds effective against several disorders of the eye in particular the cataract and composition containing them
FR2608428A1 (fr) * 1985-11-27 1988-06-24 Senju Pharma Co Composition therapeutique a base de cysteine, pour les complications diabetiques
US4794124A (en) * 1985-11-27 1988-12-27 Senju Pharmaceutical Co., Ltd. Therapeutic composition for diabetic complications
CN115094426A (zh) * 2022-08-01 2022-09-23 哈尔滨工程大学 一种基于协同机制构筑的复合缓蚀剂的制备方法
CN115094426B (zh) * 2022-08-01 2023-11-10 哈尔滨工程大学 一种基于协同机制构筑的复合缓蚀剂的制备方法

Also Published As

Publication number Publication date
DE2441621C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-01-21

Similar Documents

Publication Publication Date Title
DE3875285T2 (de) Verwendung von salzen der n-acetylneuraminsaeure zur herstellung eines arzneimittels zum abschwellen der nasenschleimhaut.
DE1617576C3 (de) Verfahren zur Herstellung eines Injektionspräparates auf Basis einer wäßrigen Lösung eines Oxytetracyclin-Magnesium-Komplexes
DE69033112T2 (de) Zink enthaltende Sprays
LU83029A1 (de) Pharmazeutischer ansatz mit einer corticosteroid-substanz
EP0002495B1 (de) Erzeugnisse zur Anwendung in der cytostatischen Therapie
DE2918799A1 (de) Ophthalmische loesung
DE69534620T2 (de) Verfahren zur behandlung von augenerkrankungen
DE2441621C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69937574T2 (de) Verwendung des pharmazeutischen präparates "histochrome" zur behandlung des akuten herzinfarkts und ischämischer herzerkrankungen
DE69013431T2 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
DE3779842T2 (de) Antiallergisches mittel.
DE1917283C3 (de) Herstellung antimikrobieller Präparate
CH636766A5 (de) Infusionsloesung zur behandlung von hepatischer encephalopathie und ein verfahren zu deren herstellung.
EP0003750B1 (de) Salze von Dithiodialkansulfonsäuren zur Verwendung bei der cytostatischen Therapie mit Alkylantien
DE4303818C1 (de) Arzneimittel mit einem Gehalt an Dexpanthenol zur topischen Anwendung
DE1768575B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2221281C3 (de) Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung
DE2844534C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0022064A2 (de) Polyvinylalkohole zur Behandlung von Wunden
DE3880498T2 (de) Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung.
DE2015877A1 (de) Arzneimittel
AT382313B (de) Verfahren zur herstellung von augenarzneiloesungen
DE2043330C3 (de) Polymere Stoffe aus l-Methyl-5-(5-OXO-4 äthyl-tetrahydrofuryl-(3)methyO-imidazol und Celluloseglykolsäure, Verfahren zu deren Herstellung und diese Stoffe enthaltende Arzneimittel
DE1047991B (de) Verfahren zur Herstellung chemisch stabiler, untoxischer, steriler Injektionsloesungen von Thioctsaeure
AT290016B (de) Verfahren zur Herstellung einer Brandsalbe

Legal Events

Date Code Title Description
OB Request for examination as to novelty
OC Search report available
8110 Request for examination paragraph 44
D2 Grant after examination
8380 Miscellaneous part iii

Free format text: SEITE 2, ZEILE 24, 25, 29 UND 30 "COLLAGEMASSE" AENDERN IN "COLLAGENASE" SEITE 2, ZEILE 36 "EXIDIERT" AENDERN IN "OXIDIERT" SEITE 4, SEITE 10 "CONJUNTIVALE" AENDERN IN "CONJUNCTIVALE"

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee